SHANDA CARTER: Open Payments
NPI 1023485935 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,028 in 105 payments from 13 companies in 2025. Trend: 2023 $1,158 · 2024 $1,740 · 2025 $2,028
Food & beverage: $2,018Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $432 |
| Janssen Biotech, Inc. | 21 | $321 |
| UCB, Inc. | 21 | $276 |
| E.R. Squibb & Sons, L.L.C. | 17 | $244 |
| GENZYME CORPORATION | 6 | $242 |
| Regeneron Healthcare Solutions, Inc. | 6 | $184 |
| Amgen Inc. | 5 | $94 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
| Galderma Laboratories, L.P. | 2 | $41 |
| Organon LLC | 2 | $41 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, Sotyktu, RINVOQ, OTEZLA, COSENTYX.
Industry payments across GA — which companies pay providers there.
